Deborah Nercolini

[Bjorn Lomborg @BjornLomborg]

How to manufacture a crisis:

A WHO commission wants to declare climate change a “global health emergency.”

Their big evidence? Rising heat deaths in Europe.

But once you adjust for an ageing society, the “crisis” essentially disappears.

Even more dishonestly, the report conceals that cold deaths have declined by approximately 250 times as much as heat deaths have risen.

https://t.co/8T5c9Hmesh

[Allan Dos Santos @allanconta5]

Bukele continua certo.

[Rafael Fontana @RafaelFontana]

Por que um evento pago pelo povo brasileiro, com participantes brasileiros, é realizado em Lisboa?

Alguém consegue explicar?

[Robert Jenrick @RobertJenrick]

Rest in peace, Henry Nowak.

His death must be a turning point for Britain.

[Mario Bohm @mcbohm]

A cada bobagem que a esquerda fala, o Brasil reage com uma sátira do mesmo nível.

Fala mais @JanjaLula.
Fala mais @LulaOficial.

[Ahmed Bennis MD 🫀 @drbennisahmed]

Efficacy and Safety of Intravenous Antiplatelet Therapy in Acute Myocardial Infarction With Cardiogenic Shock

In AMI-CS patients undergoing angiography, IV antiplatelet therapy was associated with a lower ischemic risk without an increase in major bleeding at 30 days.

#Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare
@JACCJournals @ACCinTouch @DrMarthaGulati @hvanspall @AndrewJSauer @mmamas1973 @AnastasiaSMihai @Hragy @biljana_parapid
https://t.co/Pk37XbfIzU

[Davide Capodanno @DFCapodanno]

Introducing the percutaneous aorto-coronary bypass graft. The VECTOR procedure revascularizes the left main coronary artery using retrograde and antegrade steps: a retrograde wire exits the left main (distal graft), an electrosurgical wire exits the aortic root (proximal graft), a guidewire rail is created, and a stent graft is delivered from the aorta to the left main. What could possibly go wrong?
https://t.co/iNUNbHdGiT

[Women As One @WomenAs1]

Grow with @UniofOxford's MSc in Clinical Trials.

The part-time, distance-learning course offers small-group tutorials & guidance from leading trialists. We're pleased to support this course as part of our commitment to increasing women in research.

https://t.co/UPyOctWWOY

[Deborah Nercolini @DebbieNercolini]

@ISeropianMD No. I don't think 0.5 cc makes any difference! 🤣🤣

[Ana Paula Tagliari @TagliariPaula]

Women Leading Heart
A place to build bridges 🌉, exchange knowledge 📚, and support one another 🤝

Thank you @MerilGlobal for this initiative and for the opportunity to share our cases with this amazing group of women colleagues.
@LedurPriscila @carlaagatiello1 @AlbanezTie6796 @DebbieNercolini

[European Society of Cardiology Journals @ESC_Journals]

New #EJHF expert consensus on SMR in HF: 📌 Optimize GDMT + CRT first ✔️ then select pts for TEER/transcatheter options. New RCTs📊 may shift indications https://t.co/rFx54vTfIe

@EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd

[European Society of Cardiology Journals @ESC_Journals]

Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease? Read this State-of-the-Art review in #EHJ 👉 https://t.co/izTvcZQG42

@RoccoMontone @ehj_ed

[Eric Topol @EricTopol]

Get this: Coffee suppressed atrial fibrillation!
Unexpected results for recurrence from a randomized trial in participants after cardioversion from AF
#AHA25 @JAMA_current ☕️ https://t.co/70dPI2R84C

[Deborah Nercolini @DebbieNercolini]

@gunsnrosesgirl3 1

[JACC Journals @JACCJournals]

New in #JACCINT: “New-Onset Conductance Disturbances After Transcatheter Tricuspid Valve Replacement.” This study reports a 44% incidence of conduction disturbances post-TTVR, linked to hyperdynamic RV function and device–membranous septum.

https://t.co/YAolyn5VR8

[Ahmed Bennis MD 🫀 @drbennisahmed]

Heart failure improvement, remission, and recovery: A European Journal of Heart Failureexpert consensus document

The concept of HF with improved ejection fraction (HFimpEF) underscores this complexity, identifying patients who exhibit an increase in left ventricular ejection fraction (LVEF) following time and/or pharmacological and device-based therapies.

#Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare

@gcfmd @SJGreene_md @JavedButler1 @AndrewJSauer @ankeetbhatt @hvanspall @DrMarthaGulati @hfcollaboratory @GMCRosano @HFA_President @

https://t.co/5RUMTOMkEI

[Mayra Guerrero, MD @MayraGuerreroMD]

This is a truly historic moment. The results from this pivotal trial evaluating a fully percutaneous transcatheter mitral valve replacement technology has opened a new treatment option for patients who are not good candidates for surgery or TEER. This is a remarkable milestone that will not only transform the field of interventional cardiology but, most importantly, will change the lives of countless patients who have been waiting for a viable treatment option. Slides presented as LBCT #TCT2025 today and link to our manuscript published @TheLancet today are included. Thank you to all the people who worked with us for a decade to make this happen! @DVDaniels @MayoClinicCV

https://t.co/ufEseWlevp

[Logística & Infraestrutura @LogInfra]

Trem dos Andes, chegando a 4.220 metros de altitude.

Da série: Advogado diz que trem não sobe morro.